Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-β signaling

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 19, 2011, Pages 7820-7825

  Upadhyay, Geeta ^a   Yin, Yuzhi ^a   Yuan, Hongyan ^a   Li, Xin ^b   Derynck, Rik ^c   Glazer, Robert I ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 10; SMAD3 PROTEIN; STEM CELL ANTIGEN 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CARCINOGENESIS; CARCINOGENICITY; DIMERIZATION; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR CELL;

ANIMALS; ANTIGENS, LY; BASE SEQUENCE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GREEN FLUORESCENT PROTEINS; GROWTH DIFFERENTIATION FACTOR 10; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

MURINAE; MUS;

EID: 79956348914     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1103441108     Document Type: Article

References (47)

1. Holmes C, Stanford WL (2007) Concise review. Stem cell antigen-1: Expression, function, and enigma. Stem Cells 25:1339-1347.
2. Welm B, Behbod F, Goodell MA, Rosen JM (2003) Isolation and characterization of functional mammary gland stem cells. Cell Prolif 36(Suppl 1):17-32. (Pubitemid 37521841)
3. Welm BE, et al. (2002) Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 245:42-56. (Pubitemid 34461802)
4. Deugnier MA, et al. (2006) Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dβ cell line. Dev Biol 293:414-425.
5. Seigel GM, Hackam AS, Ganguly A, Mandell LM, Gonzalez-Fernandez F (2007) Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis 13:823-832. (Pubitemid 46908324)
6. Xin L, Lawson DA, Witte ON (2005) The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 102:6942-6947. (Pubitemid 40675421)
7. Li Y, et al. (2003) Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 100:15853-15858. (Pubitemid 38021079)
8. Yin Y, Yuan H, Zeng X, Kopelovich L, Glazer RI (2009) Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification. Cancer Res 69:687-694.
9. Pérez-Caro M, et al. (2009) Cancer induction by restriction of oncogene expression to the stem cell compartment. EMBO J 28:8-20.
10. Treister A, et al. (1998) Expression of Ly-6, a marker for highly malignant murine tumor cells, is regulated by growth conditions and stress. Int J Cancer 77:306-313. (Pubitemid 28287986)
11. Hanson P, Mathews V, Marrus SH, Graubert TA (2003) Enhanced green fluorescent protein targeted to the Sca-1 (Ly-6A) locus in transgenic mice results in efficient marking of hematopoietic stem cells in vivo. Exp Hematol 31:159-167. (Pubitemid 36184641)
12. Yin Y, et al. (2005) Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profiling. Mol Carcinog 44:42-50. (Pubitemid 41216406)
13. Yin Y, et al. (2005) Peroxisome proliferator - activated receptor δ and γ agonists differentially alter tumor differentiation and progression during mammary carcinogenesis. Cancer Res 65:3950-3957. (Pubitemid 40616378)
14. Cunningham NS, et al. (1995) Growth/differentiation factor-10: A new member of the transforming growth factor-β superfamily related to bone morphogenetic protein-3. Growth Factors 12:99-109.
15. Kang JS, Liu C, Derynck R (2009) New regulatory mechanisms of TGF-β receptor function. Trends Cell Biol 19:385-394.
16. Schmierer B, Hill CS (2007) TGFβ-SMAD signal transduction: Molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8:970-982. (Pubitemid 350174642)
17. Ebner R, Chen RH, Lawler S, Zioncheck T, Derynck R (1993) Determination of type I receptor specificity by the type II receptors for TGF-β or activin. Science 262:900-902. (Pubitemid 24014077)
18. Ebner R, et al. (1993) Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 260:1344-1348. (Pubitemid 23231981)
19. Massagué J, Like B (1985) Cellular receptors for type β transforming growth factor: Ligand binding and affinity labeling in human and rodent cell lines. J Biol Chem 260:2636-2645. (Pubitemid 15139314)
20. Linke A, et al. (2005) Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 102:8966-8971. (Pubitemid 40881062)
21. Mitchell PO, et al. (2005) Sca-1 negatively regulates proliferation and differentiation of muscle cells. Dev Biol 283:240-252. (Pubitemid 40828855)
22. Chen HC, Frissora F, Durbin JE, Muthusamy N (2003) Activation induced differential regulation of stem cell antigen-1 (Ly-6A/E) expression in murine B cells. Cell Immunol 225:42-52. (Pubitemid 37468461)
23. Li Y, Rosen JM (2005) Stem/progenitor cells in mouse mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 10:17-24. (Pubitemid 40724019)
24. Luna G, Paez J, Cardier JE (2004) Expression of the hematopoietic stem cell antigen Sca-1 (LY-6A/E) in liver sinusoidal endothelial cells: Possible function of Sca-1 in endothelial cells. Stem Cells Dev 13:528-535. (Pubitemid 39473583)
25. Burger PE, et al. (2005) Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci USA 102:7180-7185. (Pubitemid 40696354)
26. Tateishi K, et al. (2007) Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration. J Cell Sci 120:1791-1800. (Pubitemid 46930417)
27. Hino J, Matsuo H, Kangawa K (1999) Bone morphogenetic protein-3b (BMP-3b) gene expression is correlated with differentiation in rat calvarial osteoblasts. Biochem Biophys Res Commun 256:419-424. (Pubitemid 29298901)
28. Kaihara S, et al. (2003) Overexpression of bone morphogenetic protein-3b (BMP-3b) using an adenoviral vector promote the osteoblastic differentiation in C2C12 cells and augment the bone formation induced by bone morphogenetic protein-2 (BMP-2) in rats. Life Sci 72:1683-1693. (Pubitemid 36136073)
29. Derynck R, Akhurst RJ, Balmain A (2001) TGF-β signaling in tumor suppression and cancer progression. Nat Genet 29:117-129. (Pubitemid 32952643)
30. Ikushima H, Miyazono K (2010) TGFβ signaling: A complex web in cancer progression. Nat Rev Cancer 10:415-424.
31. Massagué J (2008) TGFβ in cancer. Cell 134:215-230.
32. Grange C, Lanzardo S, Cavallo F, Camussi G, Bussolati B (2008) Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice. Neoplasia 10:1433-1443.
33. Cohn MA, Kramerov D, Hulgaard EF, Lukanidin EM (1997) The differentiation antigen Ly-6E.1 is expressed in mouse metastatic tumor cell lines. FEBS Lett 403:181-185. (Pubitemid 27081490)
34. + progenitors in an immortalized mammary gland cell line. J Cell Sci 120:468-477.
35. Woodward WA, et al. (2007) WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 104:618-623. (Pubitemid 46123074)
36. Roarty K, Baxley SE, Crowley MR, Frost AR, Serra R (2009) Loss of TGF-β or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype. Breast Cancer Res, 10.1186/bcr2244.
37. Naylor TL, et al. (2005) High-resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res 7:R1186-R1198.
38. Herschkowitz JI, et al. (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol, 10.1186/gb-2007-8-5-r76.
39. Choi SH, Kong HK, Park SY, Park JH (2009) Metastatic effect of LY-6K gene in breast cancer cells. Int J Oncol 35:601-607.
40. Nieuwenhuis EJ, et al. (2003) Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates. Clin Cancer Res 9:755-761. (Pubitemid 36182611)
41. Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-β family signaling. Nature 425:577-584. (Pubitemid 37280136)
42. Shi Y, Massagué J (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685-700. (Pubitemid 36724933)
43. Robinson SD, Silberstein GB, Roberts AB, Flanders KC, Daniel CW (1991) Regulated expression and growth inhibitory effects of transforming growth factor-β isoforms in mouse mammary gland development. Development 113:867-878. (Pubitemid 21900326)
44. Pierce DF, Jr., et al. (1995) Mammary tumor suppression by transforming growth factor β-1 transgene expression. Proc Natl Acad Sci USA 92:4254-4258.
45. Bierie B, et al. (2008) Transforming growth factor-β regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res 68: 1809-1819. (Pubitemid 351416566)
46. Dennler S, et al. (1998) Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091-3100.
47. Korchynskyi O, ten Dijke P (2002) Identification and functional characterization of distinct critically important bone morphogenetic protein - specific response elements in the Id1 promoter. J Biol Chem 277:4883-4891.